-
-
-
-
-
-
-
BioMarin to Participate in Two Upcoming Investor Conferences
-
-
-
-
-
-
-
BioMarin to Participate in Jefferies Gene Therapy/Editing Summit on October 8, 2019 in New York
-
-
-
-
-
-
-
Take Advantage of Biotech Pullback - Jeffereis (IBB) (VRTX) (BMRN) (MDCO) (RARE) (VNDA)
-
-
-
-
-
-
-
BioMarin's (BMRN) Confidence in Drisapersen Approvability Has Increased, Jefferies Says
-
-
-
-
-
-
-
Notable Analyst Rating Changes 10/16: (BAC) (NFLX) (CLD) Upgraded; (AKAM) (DIS) (FRAN) Downgraded
-
-
-
-
-
-
-
Notable Analyst Rating Changes 11/06: (UBS) (CMG) (AIV) Upgraded; (ESRX) (BMRN) (TWTC) Downgraded
-
-
-
-
-
-
-
Notable Analyst Rating Changes of the Day 02/08: HD, AMZN, ARAY, WGO Upgraded; BMRN, ARG, HK Downgraded
-
73,339 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

